Industries > Pharma > Global Pre-Filled Syringes Market Forecast 2019-2029

Global Pre-Filled Syringes Market Forecast 2019-2029

Glass Pre-Filled Syringes, Plastic Pre-Filled Syringes, Pen Injectors and Autoinjectors, Insulin Therapies, Rheumatoid Arthritis (RA) Therapies, Growth Hormones, Vaccines, PCSK9 Inhibitors

PUBLISHED: 31 January 2019
PAGES: 274
PRODUCT CODE: PHA0353
SUBMARKET: Medical Devices

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE

The global pre-filled syringes market was valued at $9.8bn in 2018. This market is estimated to grow at a CAGR of 12.9% in the first half of the forecast period. In 2018, the glass pre-filled syringes submarket held 53% of the global pre-filled syringes.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new report, you will find 274-page report and you will receive 101 tables and 86 figures – all unavailable elsewhere.

The 274-page report provides clear detailed insight into the global pre-filled syringes market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Pre-Filled Syringes market forecasts from 2019-2029

• Pre-Filled Syringes submarket forecasts by type from 2019-2029 covering:
• Glass Pre-Filled Syringes
• Pen Injectors and Autoinjectors
• Plastic Pre-Filled Syringes

• Forecasts from 2019-2029 of the leading therapeutic sectors for the Pre-Filled Syringes market:
• Insulin Therapies
• Rheumatoid Arthritis (RA) Therapies
• Growth Hormones
• Vaccines
• PCSK9 Inhibitors

• Pre-Filled Syringes national market forecasts from 2019-2029, covering:
• United States
• Japan
• Germany
• France
• United Kingdom
• Italy
• Spain
• Brazil
• Russia
• India
• China

Global Pre-Filled Syringes Market Forecast 2019-2029

Each national market is further segmented by type and application.

• Forecasts from 2019-2029 of selected leading products:
• Enbrel
• Genotropin
• Humalog
• Humira
• Humulin
• Lantus
• Levemir
• Norditropin
• NovoMix
• NovoRapid/Novolog
• Praluent
• Repatha
• Rituxan
• Toujeo
• Trulicity

• Assessment of the leading pre-filled syringes manufacturers and related technology manufacturers.

SWOT and STEP analysis of the global pre-filled syringes market.

Visiongain’s study is intended for anyone requiring commercial analyses for the Pre-Filled Syringes Market and leading companies. You find data, trends and predictions.

Buy our report today Global Pre-Filled Syringes Market Forecast 2019-2029: Glass Pre-Filled Syringes, Plastic Pre-Filled Syringes, Pen Injectors and Autoinjectors. Insulin Therapies. Rheumatoid Arthritis (RA) Therapies, Growth Hormones, Vaccines, PCSK9 Inhibitors.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Pre-Filled Syringes Market Forecast 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Global Pre-Filled Syringes Market Forecast 2019-2029


Latest Pharma news

“Global Influenza Vaccines Market Set to Grow to $4.9bn by 2024” says new Visiongain report

The global vaccines market is one that is driven by innovation. This is vital for maintaining the rich pipeline of vaccines seen in the human vaccines market.

05 July 2019

READ

“Pharmaceutical Wholesale & Distribution Organizations 2019 is estimated to reach $1.4bn in 2024” says Visiongain report

Opportunities in the market stem from the increasing use of specialist and generic drugs, which have higher profit margins; global expansion into the emerging markets; vertical integration of wholesalers; and the increasing use of pharmaceuticals.

28 June 2019

READ

“Global Vaccines Sales market set to grow to $75bn by 2024” says new Visiongain report

Progress in R&D in the therapeutic vaccine field will yield revolutionary results and answer unmet medical needs. This will also lead to more innovative approaches to vaccine development.

25 June 2019

READ

“Global Inflammatory Bowel Diseases (IBD) Drug Market is estimated to reach $8.6bn by 2024” says new Visiongain report

Revenue growth will be driven by rising incidence and prevalence owing to modern lifestyles and improved awareness and diagnosis.

21 June 2019

READ

Categories

Category